Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. is a state-owned holding professional pharmaceutical manufacturer, headquartered in Luancheng District, Shijiazhuang City, Hebei Province. It has three wholly-owned subsidiaries and four production areas. Since its establishment in 1997, it has focused on drug production and formed a series of product structures until now, which mainly consist of fermentation raw materials, including veterinary raw materials, veterinary preparations, feed additives and vitamins. The main products include oxytetracycline, oxytetracycline hydrochloride, streptomycin sulfate, dihydrostreptomycin sulfate, colistin sulphate, neomycin sulphate, spectinomycin sulphate, vitamin B2 and other raw materials, as well as veterinary preparations such as oxytetracycline premix. Products are sold to all countries in the world, especially in developed countries and regions such as Europe, America and Japan, which occupy a larger market share. Enterprises have been to ensure the stable supply of high-quality products for customers as the main work, enterprises continue to focus on environmental investment, a large number of environmental protection facilities have been and will continue to be put into use, to meet the government environmental standards, to be environmental benchmarking enterprises. In 2017 and 2018, there was no shutdown, which have ensured the supply of customers.
Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. is a state-owned holding professional pharmaceutical manufacturer, headquartered in Luancheng District, Shijiazhuang City, Hebei Province. It has three wholly-owned subsidiaries and four production areas. Since its establishment in 1997, it has focused on drug production and formed a series of product structures until now, which mainly consist of fermentation raw materials, including veterinary raw materials, veterinary preparations, feed additives and vitamins. The main products include oxytetracycline, oxytetracycline hydrochloride, streptomycin sulfate, dihydrostreptomycin sulfate, colistin sulphate, neomycin sulphate, spectinomycin sulphate, vitamin B2 and other raw materials, as well as veterinary preparations such as oxytetracycline premix. Products are sold to all countries in the world, especially in developed countries and regions such as Europe, America and Japan, which occupy a larger market share. Enterprises have been to ensure the stable supply of high-quality products for customers as the main work, enterprises continue to focus on environmental investment, a large number of environmental protection facilities have been and will continue to be put into use, to meet the government environmental standards, to be environmental benchmarking enterprises. In 2017 and 2018, there was no shutdown, which have ensured the supply of customers.